SCHEDULE: D. E. Shaw Entities Amend Gossamer Bio Stake
Schedule 13D Amendment
D. E. Shaw entities have filed an amendment to their Schedule 13D, reporting a combined beneficial ownership of 7.1% of Gossamer Bio, Inc. common stock.
Summary
- This filing is an amendment to a Schedule 13D concerning Gossamer Bio, Inc. (the "Issuer").
- Several D. E. Shaw entities, including D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw & Co., L.L.C., D. E. Shaw & Co., L.P., and David E. Shaw, are jointly filing this statement.
- The reporting persons collectively beneficially own 34,609,565 shares of Gossamer Bio, Inc. common stock, representing approximately 7.1% of the outstanding shares.
- This ownership is held through various D. E. Shaw entities, with D. E. Shaw & Co., L.P. acting as an investment adviser and D. E. Shaw & Co., L.L.C. acting as a manager for some of these entities.
- David E. Shaw, through his roles in parent companies, may be deemed to have shared power to vote or direct the vote of, and dispose or direct the disposition of, these shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it primarily concerns ownership disclosures and joint filing agreements rather than operational or financial performance updates.
Future Outlook
This filing is an amendment to a Schedule 13D and does not contain specific forward-looking statements or guidance from Gossamer Bio, Inc. It primarily reports on beneficial ownership changes and related agreements.
Industry Context
StockSavvy.ai notes that this filing represents a significant update regarding the beneficial ownership of Gossamer Bio, Inc. by a major investment group, D. E. Shaw. Such filings are crucial for understanding the landscape of major shareholders and potential influences on corporate strategy and governance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Joint Filing Agreement | An agreement among D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw & Co., L.L.C., D. E. Shaw & Co., L.P., and David E. Shaw to jointly file statements regarding their beneficial ownership of Gossamer Bio, Inc. common stock. | 2026-07-24 | Ensures coordinated and compliant reporting of ownership stakes by related entities. |
| Power of Attorney | David E. Shaw granted powers of attorney to specific employees of D. E. Shaw & Co., L.P. to execute regulatory filings on his behalf, including Schedule 13D amendments. | 2024-08-01 | Facilitates efficient and timely execution of regulatory documentation by authorized personnel. |
Related Party Transactions
- The filing details the relationships between D. E. Shaw Valence Portfolios, L.L.C., D. E. Shaw & Co., L.L.C., D. E. Shaw & Co., L.P., and David E. Shaw, outlining how beneficial ownership is attributed through advisory and management roles.
Stakeholder Impact
- Shareholders: Increased transparency regarding significant beneficial ownership by D. E. Shaw entities.
- Management and Board of Directors: Awareness of a substantial shareholder group's holdings and potential influence.
- Regulatory Bodies: Compliance with SEC reporting requirements for significant beneficial ownership.
Next Steps
- The reporting persons will continue to comply with all applicable regulatory disclosure requirements.
- The joint filing agreement ensures coordinated reporting of ownership changes.
Key Dates
| Date | Description |
|---|---|
| 2024-08-01 | Effective date for Powers of Attorney granted by David E. Shaw. |
| 2026-05-18 | Date of Transaction Support Agreement with the Issuer. |
| 2026-06-05 | Date of Indenture governing Senior Secured First Lien Convertible Notes due 2030 and Purchase Warrant Agreement. |
| 2026-06-09 | Date of Gossamer Bio, Inc.'s definitive proxy statement. |
| 2026-06-11 | Original Schedule 13D filing date. |
| 2026-07-01 | Date of Amendment No. 1 to Schedule 13D. |
| 2026-07-22 | Date of Event Requiring Filing of Schedule 13D Amendment No. 2. |
| 2026-07-24 | Date of Joint Filing Agreement and signatures on Amendment No. 2. |
Keywords
Gossamer Bio, Schedule 13D, D. E. Shaw, Beneficial Ownership, Securities, Investment Adviser, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.